Drug Approval | August 26, 2021
Johnson & Johnson booster dose indicate impressive results
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
_256_275.jpg)